EZH2 and neoplasm: In pancreatic cancer, EZH2 is upregulated and induces pancreatic cancer cell proliferation, cell migration and cell invasion in vitro and tumor growth and metastasis in vivo by inhibiting the expression of miR-218-5p [37].